1 / 26

Eastern Mediterranean Regional Office, World Health Organization Dr. Hossein Salehi May 20-24, 2007 Alexandria, Egypt

CAPACITY DEVELOPMENT WORKSHOP ON HEALTH SYSTEM DEVELOPMENT FOR REGIONAL COUNTRY OFFICE STAFF Tools for Policy Analysis: Cost Effectiveness Analysis Eastern Mediterranean Regional Office, World Health Organization Dr. Hossein Salehi May 20-24, 2007 Alexandria, Egypt

issac
Download Presentation

Eastern Mediterranean Regional Office, World Health Organization Dr. Hossein Salehi May 20-24, 2007 Alexandria, Egypt

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. CAPACITY DEVELOPMENT WORKSHOP ON HEALTH SYSTEM DEVELOPMENT FOR REGIONAL COUNTRY OFFICE STAFFTools for Policy Analysis: Cost Effectiveness Analysis Eastern Mediterranean Regional Office, World Health Organization Dr. Hossein Salehi May 20-24, 2007 Alexandria, Egypt

  2. Introduction; Concept of cost • Cost: • Accounting cost • Economic cost (value of foregone resources)

  3. Project A; MRI • Annual cost $1,000,000 • Annual Benefit 1,000 DALY averted • Project B; Immunization for HB • Annual cost $1,000.000 • Annual Benefit 1,600 DALY averted • Project C;(best alternative) • Annual cost $1,000,000 • Annual Benefit 1,800 DALY averted

  4. Introduction; Concept of cost; cont Opportunity cost “opportunity cost is the value of the best forgone alternative”

  5. Introduction; Concept of cost, cont • Who bear(s) the cost? • Individual (private) cost • Implementing agency cost (public cost) • Society (Social Cost) vs. Private cost

  6. Why costing? • Budgeting • Provider payment • Fee-for-Services • Capitation • Efficiency • Providers • Interventions

  7. Intervention cost • Intervention cost • Cost-Benefit Analysis (CBA) • Cost-Effectiveness Analysis (CEA) • Generalized Cost-Effectiveness Analysis (GCEA)

  8. WHO-GCEA • Attention to current inefficiencies in the allocation of resources • Context-specific CEA is too demanding for most countries • There are no international guideline for CEA

  9. CEA; Cost-Benefit ratio Cost a1 c h O Health benefits (DALYs averted)

  10. Cost a1 C1 a2 C2 h O Health benefits (DALYs averted) `

  11. a4 c4 a3 b3 a2 a1 c3 b2 b1 c2 c1

  12. a4 c4 a3 b3 a2 a1 c3 b2 b1 c2 c1

  13. League Table League Table

  14. League Table

  15. League Table

  16. WHO CHOICE Project • Prepared for 14 sub-regions: WHO political groupings and mortality strata • All results on www.who.int/choice • Country contextualization tool currently being finalized after tests in Thailand, Estonia, Sri Lanka (mental health), Ghana, Mexico

  17. Maternal and neonatal • Referral care level • Treatment of severe pre-eclampsia/eclampsia* • Antibiotics for pre-term prelabour rupture of membranes (pPROM)* • Antenatal steroids for pre-term births* • Management of obstructed labour, breech & fetal distress (OL)* • Management of severe post-partum haemorrhage (PPH)* • Management of maternal sepsis* • Emergency neonatal care (ENC) combination of 15-18 • Management of very low birth weight babies (vLBW)* • Management of severe neonatal infections* • Management of severe neonatal asphyxia* • Management of neonatal jaundice* Primary-level care including outreach Selected antenatal care interventions (ANC) combination of 1-4 • Tetanus toxoid (TT) • Screening for pre-eclampsia • Screening & treatment of asymptomatic bacteruria • Screening & treatment of syphilis Skilled maternal and immediate newborn care (SMNC) combination of 5 -8 • Normal delivery by skilled attendant • Active management of the third stage of labour • Initial management of post-partum haemorrhage (PPH) • Neonatal resuscitation • Community-based interventions • Community newborn care package combination of 19-20 • Support for breastfeeding mothers • Support for low birth weight babies • Community-based case management for neonatal pneumonia

  18. Mgmt of Post partum haemorrhage and shock 95% Antibiotics for pPROM 95% Mgmt of maternal sepsis 95% Antenatal steroids Mgmt of obstructed labour 95% Emergency newborn care 95% Pre-eclampsia/ eclampsia 95% SMNC 95% Other ANC 95% Tetanus 95% Breastfeeding and care for LBW 95% Results for Afr-E region Community-based Mgmt of pneumonia (95%) Community mgmt of pneumonia 95%

  19. Antenatal steroids95% Antibiotics for pPROM 95% Mgmt of obstructed labour 95% Screening for syphilis 95% ENC 95% Maternal sepsis 95% Resuscitation and referral care for eclampsia 95% Mgmt of PPH 95% Community mgmt of pneumonia 95% Eclampsia and screening for bacteruria 95% Normal delivery by skilled attendant 95% LBW95% Breastfeeding 95% Tetanus 95% Tetanus 80% Breastfeeding 80% Breastfeeding 50% Results for Sear-D region Results for Sear-D region

  20. Issues in GCEA • Estimating cost • Estimating health benefits • Discounting • Uncertainty • Ethical issues • Equity

  21. Ethical Issues in CEA • How should states of health and disability be evaluated? • Whose valuation? • Is value of a year of life depends on one’s age? • socioeconomic status,…? • Should health benefits be discounted? • How distribution of benefits be considered? • What priority should be given to sickest or worst off? • Large benefits to a few vs. small benefits to a large group. Which one? (Rule of rescue) • Fair chance or best outcome?

  22. Which ?

  23. CAPACITY DEVELOPMENT WORKSHOP ON HEALTH SYSTEM DEVELOPMENT FOR REGIONAL COUNTRY OFFICE STAFFTools for Policy Analysis: Cost Effectiveness Analysis Eastern Mediterranean Regional Office, World Health Organization Dr. Hossein Salehi May 20-24, 2007 Alexandria, Egypt

  24. Cost-EffectivenessThe case:You have $10,000,000. What project(s) will you select for implementation. Please consider cost-effectiveness, health conditions, ethical issue, equity,…

More Related